ACUITY OPENS UP NEW FRONTIERS IN SPATIAL 3D GENOMICS

摘要

Acuity Spatial Genomics, Inc. has completed a majority investment by Bruker Corporation. Acuity is a new venture focused on opening a new frontier in spatial 3D genomics and multiomic analyses for discovery. The novel technology platform of Acuity Spatial Genomics, enabled by an exclusive license to innovations from Harvard University, allows progress in genome-wide visualization of spatially resolved 3D chromatin architecture in individual cells and cell populations in situ.